FGFR1 and urinary bladder carcinoma: However, it is not known whether inhibiting FGFR1 can overcome PTX resistance in bladder cancer cell lines overexpressing FGFR1. To address this issue, this study examined whether FGFR1 overexpression contributes to PTX resistance and whether FGFR inhibition enhances PTX efficacy in UC.